Endovascular versus Surgical Lower Extremity Revascularization among Patients with Chronic Kidney Disease

Table 2

Median follow-up (in person-years (PY) and incidence of the specified outcomes of interest).

	Endovascular			Surgical			Adjusted HR (95% CI)
	Follow-up, median PY	Events, N(%)	Incidence (per 100 PY)	Follow-up, median PY	Events, N(%)	Incidence (per 100 PY)
Major adverse limb events (MALE)	0.7	23,135 (39%)	30.1	0.8	2476 (27%)	18.7	1.52 (1.46–1.59)
Repeat revascularization	0.7	20,917 (35%)	26.3	0.9	2102 (23%)	15.2	1.65 (1.57–1.72)
Amputation	1.5	2896 (5%)	2.5	1.3	486 (5%)	2.9	0.81 (0.73–0.89)
Death	1.4	24,075 (40%)	21.5	1.3	4128 (44%)	24.9	0.85 (0.82–0.88)

Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) include the inverse probability of treatment weights and compare patients with chronic kidney disease undergoing an initial endovascular versus surgical revascularization.